A putative class action targeting Rodan + Fields, LLC in California federal court could draw fresh attention to the use of prostaglandin analogs in cosmetic eyelash enhancers, an issue that has sparked FDA enforcement action in the past, as well as unfair competition suits from Latisse owner Allergan plc.
Filed April 13 in California’s Northern District, Oakland Division, the suit is based on the premise that “disclosing the true...



